Publications Page Hero Image

Our industry-recognized Education team is committed to sharing program findings, best practices, insights, and trends from our educational programs across a range of therapeutic areas. These findings are regularly published in peer-reviewed journals, as well as presented at medical, patient, and industry conferences.

CME Improves Clinicians’ Knowledge of Tailored Cancer Treatment

Immune checkpoint inhibitors have brought tailored treatments for patients with a variety of cancers. This is changing the face of treatment and the practice patterns clinicians have for everything from diagnosis to testing, adverse event management, and survivorship care.  To help clinicians prepare for these changes, PlatformQ Health and the...

Society of Paediatric Oncology Congress: PlatformQ Health and Pediatric Oncology Partners Tackle Clinician Knowledge Gaps in Pediatric Neuroblastoma

Emerging treatments such as anti-GD2 therapies are improving outcomes for children with relapsed/refractory, high-risk neuroblastoma. The changing therapeutic landscape has left knowledge gaps, with clinicians needing assistance with understanding how to integrate new agents, administer new treatments, and manage associated side effects. To address these issues, PlatformQ Health teamed up...

Setting the Industry Standard for Education Outcomes: 2021 Conference Recap

The Accreditation Council for Continuing Medical Education reports that approximately 1,680 accredited education providers offered more than 170,000 educational activities in the past year alone, yet many providers lack the ability to track the effectiveness of the programs. Assessing the actual outcomes of continuing medical education (CME) is essential. That...

American Society of Retina Specialists 39th Annual Scientific Meeting: Anti-VEGF training shows improved patient experiences

The pandemic has left clinicians who offer anti-VEGF therapy challenged to incorporate new procedures into clinical practice amid the need to add screening strategies to reduce transmission risk. To support U.S. retinal specialists and ophthalmologists who deliver anti-VEGF therapy to patients with diabetic retinopathy, diabetic macular edema, neovascular age-related macular...

HFSA Scientific Meeting 2021: CME Course Addresses Disparities in Diagnosis & Treatment of Heart Failure in Women

Heart disease remains a major cause of morbidity, hospitalizations, and mortality, particularly in women. Women experience a higher symptom burden than men, are more frequently misdiagnosed, and are underrepresented in clinical trials for health failure treatment. To address these gaps, PlatformQ Health and the American Society for Preventive Cardiology launched...

WMS 2021 Virtual Congress: Duchenne Muscular Dystrophy Education Yields Positive Outcomes

Early diagnosis and intervention is crucial for improving the quality of life of patients with Duchenne Muscular Dystrophy. However, emerging guidelines and therapeutic advances have brought about competency gaps in understanding mutation-specific treatments and more. To address these gaps, PlatformQ Health, Parent Project Muscular Dystrophy, and the National Organization of...

Outcomes from HER2/HER3 Targeted Therapies CME Series Shared at ASCO 2021

PlatformQ Health is pleased to announce the publication of a poster at the 2021 ASCO Annual Meeting. Incorporating HER2/HER3 Targeted Therapies Across Solid Tumors: Addressing the Impact of Digital Education on Clinician Practice Patterns shares insights from a multi-session CME activity, Getting to Know HER: An In-Depth Discussion on HER2/HER3-Targeted...

Rare Cancers Summit Highlighted in ASCO 2021 Abstract

Rare cancers and rare blood disorders present challenges to clinicians related to diagnosis and management. To shorten the diagnostic journey and improve clinician index of suspicion and management of rare cancers, the first annual NORD Rare Cancers Summit was launched in 2020. Partnering with NORD on this initiative was critical...

Clinician/Patient Tethered Education Initiative’s Outcomes Highlighted in ASCO 2021 Abstract

The 2021 ASCO Annual Meeting showcases what is possible when the cancer care community comes together to advance cancer research, treatment, and patient care. The abstract, Patient and Provider Education on HER2-Positive Metastatic Breast Cancer: Defining Gaps in Clinician Practice, Patient Behaviors, Patient-Provider Alignment, and Clinical Knowledge highlights key findings...